Pulmonary Disease Doctors in Allentown, PA Accepting Medicare

17 Pulmonary Disease doctors found. Showing 1 - 17

Jonathan Hertz, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Dr. Brian Robert Miller, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd Ste 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Richard J Strobel, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Joseph E Vincent, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1250 S Cedar Crest Blvd, Ste 205, Allentown, PA 18103 Phone: 610-439-8856

C Gerard Petersen, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-439-8856

Francis Schwiep, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Nicholas Joel Hinds, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd Ste 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Robert J Kruklitis, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Joseph B Schellenberg, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Dr. Aparna Kumar, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd Ste 205, Allentown, PA 18103 Phone: 610-402-9116

Dr. Jay B Lipschutz, Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3110 Hamilton Blvd, Allentown, PA 18103 Phone: 610-776-4380    Fax: 610-776-4395

Scott Frederick Michael Blumhof, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd Ste 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Dr. Jennifer Christine Rovella, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Dr. Andres Zirlinger, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Ste 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Brian Kendall Civic, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Matthew M Mccambridge, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

Jonaid Aslam, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-9116    Fax: 610-402-9610

News Archive

Report highlights health and economic impact of antimicrobial resistance in Canada

In Canada, 26% of infections are resistant to the medicines that are generally first prescribed to treat an infection, a rate that could rise to 40% or beyond in the coming decades, according to an expert panel convened by the Council of Canadian Academies. By 2050, a total of 396,000 lives could be lost and the Canadian economy could lose $388 billion per year.

Vertex Pharmaceuticals reports underwriters purchase additional stock at 38.50 per share

Vertex Pharmaceuticals Incorporated today announced that the underwriters of its public offering have exercised in full their option to purchase an additional 1,500,000 shares of common stock at the public offering price of $38.50 per share.

Athera Biotechnologies, Electra-Box Diagnostica sign distribution agreement for 'CVDefine' kit

Athera Biotechnologies and Electra-Box Diagnostica, announced today that they have signed an agreement for distribution of "CVDefine" kit. CVDefine measures a new biomarker in blood, a specific anti-body, that has been linked to increased risk for cardiovascular disease. Athera Biotechnologies is part of the Karolinska Development portfolio.

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.

FDA approves new drug Enbrel for psoriasis

The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.

Read more Medical News

› Verified 4 days ago